Felix Baker is Director & 10% Owner at SEATTLE GENETICS INC /WA (SGEN). They have made 257 open-market trades across 28 companies since 2006, most recently 2026-01-02.
195 open-market purchases totalling $2.2B since 2006, against 62 sales. Across 120 scored buys the stock is up 5.9% at ninety days, and 3.9 points ahead of the S&P over the same stretch.
120 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 30% | 33% |
| Avg Move | -7.7% | +1.8% | +5.9% |
| Alpha | -4.4% | +0.6% | +3.9% |
| Scored | 120 | 120 | 120 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 83% | 91% | 70% |
| Avg Move | -9.8% | -2.7% | -3.8% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KYMR | BUY | 2025-12-11 | 2025-12-11 | $86.00 | $172.5M | -7.3% | -18.9% | -9.5% |
| TRDA | BUY | 2025-11-20 | 2025-11-24 | $9.07 | $502K | +1.7% | +4.2% | +11.2% |
| MDGL | BUY | 2025-08-18 | 2025-08-20 | $364.11 | $48.5M | +9.8% | +10.7% | +40.7% |
| KALA | BUY | 2024-12-30 | 2024-12-31 | $6.44 | $4.0M | -10.0% | +28.3% | -22.5% |
| MDGL | BUY | 2023-11-13 | 2023-11-15 | $147.00 | $31.4M | +13.3% | +40.7% | +21.5% |
| KOD | BUY | 2022-05-25 | 2022-05-27 | $6.76 | $4.3M | +20.9% | +19.5% | +60.2% |
| INCY | BUY | 2022-02-17 | 2022-02-22 | $67.96 | $71.5M | +1.9% | +13.7% | +11.9% |
| KOD | BUY | 2022-01-21 | 2022-01-25 | $57.47 | $55.2M | +2.9% | -85.2% | -89.8% |
| BGNE | SELL | 2021-01-04 | 2021-01-06 | $220.50 | $26.7M | +37.0% | +42.8% | +26.4% |
| BGNE | SELL | 2020-12-04 | 2020-12-04 | $220.50 | $666.6M | +8.6% | +14.5% | +26.9% |
| KOD | BUY | 2020-09-25 | 2020-09-25 | $56.64 | $5.4M | +13.0% | +62.5% | +158.9% |
| SGEN | SELL | 2020-05-06 | 2020-05-08 | $161.83 | $339.8M | +0.1% | -3.1% | +3.9% |
| KOD | BUY | 2020-03-16 | 2020-03-18 | $39.30 | $11.7M | +25.1% | +32.4% | +61.0% |
| ACAD | BUY | 2020-03-16 | 2020-03-18 | $32.05 | $67.1M | +23.2% | +45.8% | +41.1% |
| KOD | BUY | 2019-12-06 | 2019-12-06 | $46.00 | $87.5M | +1.3% | +4.2% | +1.3% |
| IGMS | BUY | 2019-09-20 | 2019-09-20 | $16.00 | $50.3M | -18.6% | -11.5% | +70.6% |
| AQXP | BUY | 2019-08-07 | 2019-08-08 | $3.04 | $848K | N/A | N/A | N/A |
| AQXP | BUY | 2019-08-06 | 2019-08-08 | $2.85 | $187K | N/A | N/A | N/A |
| AQXP | BUY | 2019-08-06 | 2019-08-08 | $3.00 | $1.1M | N/A | N/A | N/A |
| ALXN | SELL | 2019-05-30 | 2019-05-30 | $120.97 | $6.9M | -1.2% | +10.7% | -6.1% |
| ALXN | SELL | 2019-05-29 | 2019-05-30 | $122.20 | $14.5M | -1.2% | +10.7% | -6.1% |
| ALXN | SELL | 2019-05-28 | 2019-05-30 | $123.77 | $36.6M | -1.2% | +10.7% | -6.1% |
| ALXN | SELL | 2019-05-28 | 2019-05-30 | $126.53 | $15.6M | -1.2% | +10.7% | -6.1% |
| GHDX | SELL | 2019-04-12 | 2019-04-12 | $65.32 | $1.4M | +2.4% | -12.2% | -13.4% |
| GHDX | SELL | 2019-04-10 | 2019-04-10 | $69.12 | $1.8M | -4.2% | -15.4% | -16.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| KOD | 1,251,349 | $107.3M |
| XOMA | 2,513,616 | $101.3M |
| BCRX | 12,894,240 | $100.4M |
| ACAD | 3,521,613 | $67.4M |
| BCYC | 10,018,674 | $34.6M |
| ARDC | 777,506 | $8.8M |
| AQXP | 1,177,013 | $4.3M |
| TRDA | 380,152 | $1.7M |
| IGMS | 274,560 | $349K |
| IDRA | 21,929 | $158K |
| NVTA | 845,858 | $75K |
| KALA | 118,496 | $22K |
| MRTX | 137 | $8K |
| TZYM | 3,290,162 | — |
| VPHM | 9,840,469 | — |
| IBPI | 15,372 | — |
| ADLR | 6,666,436 | — |
| IDP | 418,030 | — |
| GEVA | 680,187 | — |
| NRGN | 3,500,059 | — |
| PCYC | 557,211 | — |
| RDEA | 99,636 | — |
| ALTH | 5,159 | — |
| TPPH | 7,085 | — |
| TRMS | 384 | — |
| Total | $4.2B |
Shares reported on the most recent Form 4, priced at the 2026-01-06 close. 12 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 23 | 23 | 23 |